Version 5.4
Bos taurus Gene: CFDP1
Summary
InnateDB Gene IDBG-629114.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol CFDP1
Gene Name Craniofacial development protein 1
Synonyms BCNT
Species Bos taurus
Ensembl Gene ENSBTAG00000015427
Encoded Proteins
IDBP-680511
Craniofacial development protein 1
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000153774:
Gene Information
Type Protein coding
Genomic Location Chromosome 18:2662463-2766583
Strand Reverse strand
Band
Transcripts
ENSBTAT00000020504 ENSBTAP00000020504
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 5 interaction(s) predicted by orthology.
Predicted by orthology
Total 5 [view]
Gene Ontology

Molecular Function
Accession GO Term
Biological Process
GO:0007155 cell adhesion
GO:0007275 multicellular organismal development
GO:0008360 regulation of cell shape
GO:0042127 regulation of cell proliferation
GO:2000270 negative regulation of fibroblast apoptotic process
Cellular Component
Orthologs
Species
Homo sapiens
Mus musculus
Gene ID
Gene Order
ENSG00000153774
View Gene Order
ENSMUSG00000031954
View Gene Order
Cross-References
SwissProt Q8HXY9
TrEMBL Q18MX8
UniProt Splice Variant
Entrez Gene 281682
UniGene
RefSeq NM_174268
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL AB081003 AB081004 AB081095 AB263707 BC112462
GenPept AAI12463 BAC11952 BAC11953 BAC15593 BAE96744
RNA Seq Atlas 281682

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca